{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:09:04Z","timestamp":1794380944658,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003551","name":"Royal Canin","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003551","name":"Royal Canin","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003551","name":"Royal Canin","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003551","name":"Royal Canin","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003551","name":"Royal Canin","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003551","name":"Royal Canin","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003551","name":"Royal Canin","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003551","name":"Royal Canin","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100003551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Canine chronic enteropathies (CE) are a group of disorders defined by persistent or recurrent clinical signs of gastrointestinal disease without a primary neoplastic, metabolic, parasitic, or other infectious cause. In this prospective, multicentre, uncontrolled, open-label study, a commercial dry diet with a protein source of extensively hydrolysed poultry feather was assessed in the management of dogs with CE that had not responded to previous dietary and antibacterial therapies. Dogs with moderate or marked protein-losing enteropathy were excluded. After screening, dogs entered stage 1 and started the test diet. Gastrointestinal endoscopy was performed, and only dogs with histopathological evidence of small intestinal inflammation confirming CE could continue to stage 2 of the trial. The test diet was fed for 10 weeks throughout stages 1 and 2, and the primary outcome measure was clinical success defined as a reduction in canine inflammatory bowel disease activity index (CIBDAI) of \u2265\u200975%. Secondary outcomes included body condition score (BCS, scale 1\u20139) and faecal consistency score (scale 1\u20135). Results (median [range]) for dogs with confirmed CE that participated in both study stages are reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 15 dogs commenced stage 1, and 13 of these progressed to stage 2 (age 4.2 [1.1\u20137.1] years; BCS 3 (2\u20134); previous diet therapies 2 [1\u20133]) of which two were withdrawn at week 5 for protocol deviations. CIBDAI scores decreased from 9 (7\u201316;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913) at baseline to 2 (1\u201311;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913) at week 2 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), 2 (0\u20136;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913) at week 5 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and 1 (0\u20133;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911) at week 10 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Treatment success was achieved by 8\/13 dogs at week 5 and 10\/11 dogs at week 10. Faecal score (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911) and BCS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911) improved between baseline (1 [1\u20133] and 3 [3\u20134], respectively;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and week 10 (4 [3\u20135] and 4 [3\u20135], respectively;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Dogs with CE that had failed to respond to previous dietary and antibacterial therapy showed clinical improvement within 10 weeks when fed a dry extruded diet with a single protein source hydrolysed to amino acids and oligopeptides, without concurrent immunosuppressant treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12917-025-04528-y","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T07:18:41Z","timestamp":1739603921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["An extensively hydrolysed protein-based extruded diet in the treatment of dogs with chronic enteropathy and at least one previous diet-trial failure: a pilot uncontrolled open-label study"],"prefix":"10.1186","volume":"21","author":[{"given":"Val\u00e9rie","family":"Freiche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dossin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Mougeot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Laxalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Biourge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"German","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"11","key":"4528_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/jsap.12588","volume":"57","author":"JR Dandrieux","year":"2016","unstructured":"Dandrieux JR. Inflammatory bowel disease versus chronic enteropathy in dogs: are they one and the same? J Small Anim Pract. 2016;57(11):589\u201399. https:\/\/doi.org\/10.1111\/jsap.12588.","journal-title":"J Small Anim Pract"},{"issue":"9","key":"4528_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/avj.12846","volume":"97","author":"J Dandrieux","year":"2019","unstructured":"Dandrieux J, Martinez Lopez LM, Prakash N, Mansfield CS. Treatment response and long term follow up in nineteen dogs diagnosed with chronic enteropathy in Australia. Aust Vet J. 2019;97(9):301\u20137. https:\/\/doi.org\/10.1111\/avj.12846.","journal-title":"Aust Vet J"},{"issue":"2","key":"4528_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cvsm.2011.02.003","volume":"41","author":"KW Simpson","year":"2011","unstructured":"Simpson KW, Jergens AE. Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease. Vet Clin North Am Small Anim Pract. 2011;41(2):381\u201398. https:\/\/doi.org\/10.1016\/j.cvsm.2011.02.003.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"4","key":"4528_CR4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/jvim.14739","volume":"31","author":"M Volkmann","year":"2017","unstructured":"Volkmann M, Steiner JM, Fosgate GT, Zentek J, Hartmann S, Kohn B. Chronic diarrhea in dogs - retrospective study in 136 cases. J Vet Intern Med. 2017;31(4):1043\u201355. https:\/\/doi.org\/10.1111\/jvim.14739.","journal-title":"J Vet Intern Med"},{"key":"4528_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.rvsc.2018.11.019","volume":"122","author":"N Eissa","year":"2019","unstructured":"Eissa N, Kittana H, Gomes-Neto JC, Hussein H. Mucosal immunity and gut microbiota in dogs with chronic enteropathy. Res Vet Sci. 2019;122:156\u201364. https:\/\/doi.org\/10.1016\/j.rvsc.2018.11.019.","journal-title":"Res Vet Sci"},{"issue":"1\u20132","key":"4528_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.vetimm.2014.06.003","volume":"161","author":"A Kathrani","year":"2014","unstructured":"Kathrani A, Lee H, White C, Catchpole B, Murphy A, German A, Werling D, Allenspach K. Association between nucleotide oligomerisation domain two (Nod2) gene polymorphisms and canine inflammatory bowel disease. Vet Immunol Immunopathol. 2014;161(1\u20132):32\u201341. https:\/\/doi.org\/10.1016\/j.vetimm.2014.06.003.","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"4528_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jvim.15345","volume":"33","author":"K Makielski","year":"2019","unstructured":"Makielski K, Cullen J, O\u2019Connor A, Jergens AE. Narrative review of therapies for chronic enteropathies in dogs and cats. J Vet Intern Med. 2019;33(1):11\u201322. https:\/\/doi.org\/10.1111\/jvim.15345.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"4528_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s40168-019-0740-4","volume":"7","author":"S Wang","year":"2019","unstructured":"Wang S, Martins R, Sullivan MC, Friedman ES, Misic AM, El-Fahmawi A, De Martinis ECP, O\u2019Brien K, Chen Y, Bradley C, Zhang G, Berry ASF, Hunter CA, Baldassano RN, Rondeau MP, Beiting DP. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids. Microbiome. 2019;7(1):126. https:\/\/doi.org\/10.1186\/s40168-019-0740-4.","journal-title":"Microbiome"},{"issue":"2","key":"4528_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cvsm.2011.02.005","volume":"41","author":"FP Gaschen","year":"2011","unstructured":"Gaschen FP, Merchant SR. Adverse food reactions in dogs and cats. Vet Clin North Am Small Anim Pract. 2011;41(2):361\u201379. https:\/\/doi.org\/10.1016\/j.cvsm.2011.02.005.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"4528_CR10","doi-asserted-by":"publisher","first-page":"923013","DOI":"10.3389\/fvets.2022.923013","volume":"9","author":"AE Jergens","year":"2022","unstructured":"Jergens AE, Heilmann RM. Canine chronic enteropathy-current state-of-the-art and emerging concepts. Front Vet Sci. 2022;9:923013. https:\/\/doi.org\/10.3389\/fvets.2022.923013.","journal-title":"Front Vet Sci"},{"issue":"15","key":"4528_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/vr.103557","volume":"178","author":"K Allenspach","year":"2016","unstructured":"Allenspach K, Culverwell C, Chan D. Long-term outcome in dogs with chronic enteropathies: 203 cases. Vet Rec. 2016;178(15):368. https:\/\/doi.org\/10.1136\/vr.103557.","journal-title":"Vet Rec"},{"issue":"4","key":"4528_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1892\/0891-6640(2007)21[700:ceideo]2.0.co;2","volume":"21","author":"K Allenspach","year":"2007","unstructured":"Allenspach K, Wieland B, Grone A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med. 2007;21(4):700\u20138. https:\/\/doi.org\/10.1892\/0891-6640(2007)21[700:ceideo]2.0.co;2.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"4528_CR13","first-page":"219","volume":"31","author":"I Bignone","year":"2017","unstructured":"Bignone I, Tomassone L, Lotti U, Gianella P. Chronic enteropathy food-and immunosuppressant-responsive: comparison of clinicopathological findings and follow-up. Vet (Cremona). 2017;31(4):219\u201326.","journal-title":"Vet (Cremona)"},{"issue":"3\u20134","key":"4528_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.vetimm.2015.10.008","volume":"168","author":"RM Heilmann","year":"2015","unstructured":"Heilmann RM, Suchodolski JS. Is inflammatory bowel disease in dogs and cats associated with a th1 or th2 polarization? Vet Immunol Immunopathol. 2015;168(3\u20134):131\u20134. https:\/\/doi.org\/10.1016\/j.vetimm.2015.10.008.","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"4528_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/vr.105172","volume":"186","author":"C T\u00f8rnqvist-Johnsen","year":"2020","unstructured":"T\u00f8rnqvist-Johnsen C, Campbell S, Gow A, Bommer NX, Salavati S, Mellanby RJ. Investigation of the efficacy of a dietetic food in the management of chronic enteropathies in dogs. Vet Rec. 2020;186(1):22\u20136. https:\/\/doi.org\/10.1136\/vr.105172.","journal-title":"Vet Rec"},{"issue":"7","key":"4528_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1748-5827.2004.tb00245.x","volume":"45","author":"M Craven","year":"2004","unstructured":"Craven M, Simpson JW, Ridyard AE, Chandler ML. Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995\u20132002). J Small Anim Pract. 2004;45(7):336\u201342. https:\/\/doi.org\/10.1111\/j.1748-5827.2004.tb00245.x.","journal-title":"J Small Anim Pract"},{"issue":"4","key":"4528_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jsap.13122","volume":"61","author":"M Cerquetella","year":"2020","unstructured":"Cerquetella M, Rossi G, Suchodolski JS, Schmitz SS, Allenspach K, Rodr\u00edguez-Franco F, Furlanello T, Gavazza A, Marchegiani A, Unterer S, Burgener IA, Pengo G, Jergens AE. Proposal for rational antibacterial use in the diagnosis and treatment of dogs with chronic diarrhoea. J Small Anim Pract. 2020;61(4):211\u20135. https:\/\/doi.org\/10.1111\/jsap.13122.","journal-title":"J Small Anim Pract"},{"key":"4528_CR18","doi-asserted-by":"publisher","unstructured":"Cave NJ. Hydrolyzed protein diets for dogs and cats. Vet Clin North Am Small Anim Pract. 2006;36(6):1251-68, vi. https:\/\/doi.org\/10.1016\/j.cvsm.2006.08.008","DOI":"10.1016\/j.cvsm.2006.08.008"},{"issue":"3","key":"4528_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2222.1997.tb00711.x","volume":"27","author":"H Awazuhara","year":"1997","unstructured":"Awazuhara H, Kawai H, Maruchi N. Major allergens in soybean and clinical significance of IgG4 antibodies investigated by IgE- and IgG4-immunoblotting with sera from soybean-sensitive patients. Clin Exp Allergy. 1997;27(3):325\u201332.","journal-title":"Clin Exp Allergy"},{"issue":"3\u20134","key":"4528_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.vetimm.2007.07.006","volume":"120","author":"S Kleinschmidt","year":"2007","unstructured":"Kleinschmidt S, Meneses F, Nolte I, Hewicker-Trautwein M. Characterization of mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with lymphocytic-plasmacytic or eosinophilic gastroenterocolitis. Vet Immunol Immunopathol. 2007;120(3\u20134):80\u201392. https:\/\/doi.org\/10.1016\/j.vetimm.2007.07.006.","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"4528_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cvsm.2020.09.005","volume":"51","author":"A Kathrani","year":"2021","unstructured":"Kathrani A. Dietary and nutritional approaches to the management of chronic enteropathy in dogs and cats. Vet Clin North Am Small Anim Pract. 2021;51(1):123\u201336. https:\/\/doi.org\/10.1016\/j.cvsm.2020.09.005.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"4528_CR22","doi-asserted-by":"publisher","unstructured":"Siel D, Beltr\u00e1n CJ, Mart\u00ednez E, Pino M, Vargas N, Salinas A, P\u00e9rez O, Pereira I, Ram\u00edrez-Toloza G. Elucidating the role of innate and adaptive immune responses in the pathogenesis of canine chronic inflammatory enteropathy-a search for potential biomarkers. Anim (Basel). 2022;12(13). https:\/\/doi.org\/10.3390\/ani12131645.","DOI":"10.3390\/ani12131645"},{"issue":"1","key":"4528_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jvim.12023","volume":"27","author":"S Maeda","year":"2013","unstructured":"Maeda S, Ohno K, Uchida K, Nakashima K, Fukushima K, Tsukamoto A, Nakajima M, Fujino Y, Tsujimoto H. Decreased immunoglobulin a concentrations in feces, duodenum, and peripheral blood mononuclear cells of dogs with inflammatory bowel disease. J Vet Intern Med. 2013;27(1):47\u201355. https:\/\/doi.org\/10.1111\/jvim.12023.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"4528_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/0300985815591081","volume":"53","author":"S Maeda","year":"2016","unstructured":"Maeda S, Ohno K, Fujiwara-Igarashi A, Uchida K, Tsujimoto H. Changes in foxp3-positive regulatory t cell number in the intestine of dogs with idiopathic inflammatory bowel disease and intestinal lymphoma. Vet Pathol. 2016;53(1):102\u201312. https:\/\/doi.org\/10.1177\/0300985815591081.","journal-title":"Vet Pathol"},{"issue":"6","key":"4528_CR25","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/jvim.12456","volume":"28","author":"E Haas","year":"2014","unstructured":"Haas E, R\u00fctgen BC, Gerner W, Richter B, Tichy A, Galler A, Bilek A, Thalhammer JG, Saalm\u00fcller A, Luckschander-Zeller N. Phenotypic characterization of canine intestinal intraepithelial lymphocytes in dogs with inflammatory bowel disease. J Vet Intern Med. 2014;28(6):1708\u201315. https:\/\/doi.org\/10.1111\/jvim.12456.","journal-title":"J Vet Intern Med"},{"key":"4528_CR26","doi-asserted-by":"publisher","first-page":"101418","DOI":"10.1016\/j.smim.2020.101418","volume":"50","author":"J Sidney","year":"2020","unstructured":"Sidney J, Peters B, Sette A. Epitope prediction and identification- adaptive T cell responses in humans. Semin Immunol. 2020;50:101418. https:\/\/doi.org\/10.1016\/j.smim.2020.101418.","journal-title":"Semin Immunol"},{"issue":"1\u20132","key":"4528_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molimm.2012.06.001","volume":"53","author":"JV Kringelum","year":"2013","unstructured":"Kringelum JV, Nielsen M, Padkj\u00e6r SB, Lund O. Structural analysis of b-cell epitopes in antibody:protein complexes. Mol Immunol. 2013;53(1\u20132):24\u201334. https:\/\/doi.org\/10.1016\/j.molimm.2012.06.001.","journal-title":"Mol Immunol"},{"issue":"7","key":"4528_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/mnfr.200500272","volume":"50","author":"EF Knol","year":"2006","unstructured":"Knol EF. Requirements for effective IgE cross-linking on mast cells and basophils. Mol Nutr Food Res. 2006;50(7):620\u20134. https:\/\/doi.org\/10.1002\/mnfr.200500272.","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"4528_CR29","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/j.1939-1676.2010.0632.x","volume":"24","author":"PJ Mandigers","year":"2010","unstructured":"Mandigers PJ, Biourge V, van den Ingh TS, Ankringa N, German AJ. A randomized, open-label, positively-controlled field trial of a hydrolyzed protein diet in dogs with chronic small bowel enteropathy. J Vet Intern Med. 2010;24(6):1350\u20137. https:\/\/doi.org\/10.1111\/j.1939-1676.2010.0632.x.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"4528_CR30","first-page":"109","volume":"3","author":"SL Marks","year":"2002","unstructured":"Marks SL, Laflamme DP, McAloose D. Dietary trial using a commercial hypoallergenic diet containing hydrolyzed protein for dogs with inflammatory bowel disease. Vet Ther. 2002;3(2):109\u201318.","journal-title":"Vet Ther"},{"issue":"1","key":"4528_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/gut.36.1.60","volume":"36","author":"JC Mansfield","year":"1995","unstructured":"Mansfield JC, Giaffer MH, Holdsworth CD. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn\u2019s disease. Gut. 1995;36(1):60\u20136. https:\/\/doi.org\/10.1136\/gut.36.1.60.","journal-title":"Gut"},{"issue":"6","key":"4528_CR32","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1111\/jvim.16846","volume":"37","author":"AC Manchester","year":"2023","unstructured":"Manchester AC, Dow S, Chow L, Gagne J, Lappin MR. Efficacy of an elemental diet in achieving clinical remission in dogs with chronic enteropathy. J Vet Intern Med. 2023;37(6):2322\u201333. https:\/\/doi.org\/10.1111\/jvim.16846.","journal-title":"J Vet Intern Med"},{"key":"4528_CR33","doi-asserted-by":"publisher","unstructured":"Lesponne I, Naar J, Planchon S, Serchi T, Montano M. DNA and protein analyses to confirm the absence of cross-contamination and support the clinical reliability of extensively hydrolysed diets for adverse food reaction-pets. Vet Sci. 2018;5(3). https:\/\/doi.org\/10.3390\/vetsci5030063.","DOI":"10.3390\/vetsci5030063"},{"issue":"1","key":"4528_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12917-017-1183-4","volume":"13","author":"T Olivry","year":"2017","unstructured":"Olivry T, Bexley J, Mougeot I. Extensive protein hydrolyzation is indispensable to prevent IgE-mediated poultry allergen recognition in dogs and cats. BMC Vet Res. 2017;13(1):251. https:\/\/doi.org\/10.1186\/s12917-017-1183-4.","journal-title":"BMC Vet Res"},{"issue":"4","key":"4528_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/vde.12302","volume":"27","author":"P Bizikova","year":"2016","unstructured":"Bizikova P, Olivry T. A randomized, double-blinded crossover trial testing the benefit of two hydrolysed poultry-based commercial diets for dogs with spontaneous pruritic chicken allergy. Vet Dermatol. 2016;27(4):289\u2013e70. https:\/\/doi.org\/10.1111\/vde.12302.","journal-title":"Vet Dermatol"},{"issue":"1","key":"4528_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/jvim.15638","volume":"34","author":"S Kather","year":"2020","unstructured":"Kather S, Grutzner N, Kook PH, Dengler F, Heilmann RM. Review of cobalamin status and disorders of cobalamin metabolism in dogs. J Vet Intern Med. 2020;34(1):13\u201328. https:\/\/doi.org\/10.1111\/jvim.15638.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"4528_CR37","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1172\/JCI109020","volume":"61","author":"JH Cummings","year":"1978","unstructured":"Cummings JH, Wiggins HS, Jenkins DJ, Houston H, Jivraj T, Drasar BS, Hill MJ. Influence of diets high and low in animal fat on bowel habit, gastrointestinal transit time, fecal microflora, bile acid, and fat excretion. J Clin Invest. 1978;61(4):953\u201363. https:\/\/doi.org\/10.1172\/JCI109020.","journal-title":"J Clin Invest"},{"key":"4528_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12917-016-0676-x","volume":"12","author":"S Segarra","year":"2016","unstructured":"Segarra S, Mart\u00ednez-Subiela S, Cerd\u00e0-Cu\u00e9llar M, Mart\u00ednez-Puig D, Mu\u00f1oz-Prieto A, Rodr\u00edguez-Franco F, Rodr\u00edguez-Bertos A, Allenspach K, Velasco A, Cer\u00f3n J. Oral chondroitin sulfate and prebiotics for the treatment of canine inflammatory bowel disease: a randomized, controlled clinical trial. BMC Vet Res. 2016;12:49. https:\/\/doi.org\/10.1186\/s12917-016-0676-x.","journal-title":"BMC Vet Res"},{"issue":"4","key":"4528_CR39","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/jvim.12093","volume":"27","author":"D Walker","year":"2013","unstructured":"Walker D, Knuchel-Takano A, McCutchan A, Chang YM, Downes C, Miller S, Stevens K, Verheyen K, Phillips AD, Miah S, Turmaine M, Hibbert A, Steiner JM, Suchodolski JS, Mohan K, Eastwood J, Allenspach K, Smith K, Garden OA. A comprehensive pathological survey of duodenal biopsies from dogs with diet-responsive chronic enteropathy. J Vet Intern Med. 2013;27(4):862\u201374. https:\/\/doi.org\/10.1111\/jvim.12093.","journal-title":"J Vet Intern Med"},{"issue":"430","key":"4528_CR40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1651-2227.1999.tb01309.x","volume":"88","author":"L Businco","year":"1999","unstructured":"Businco L, Bruno G, Giampietro PG. Prevention and management of food allergy. Acta Paediatr Suppl. 1999;88(430):104\u20139. https:\/\/doi.org\/10.1111\/j.1651-2227.1999.tb01309.x.","journal-title":"Acta Paediatr Suppl"},{"issue":"12","key":"4528_CR41","doi-asserted-by":"publisher","first-page":"e0226780","DOI":"10.1371\/journal.pone.0226780","volume":"14","author":"T Atherly","year":"2019","unstructured":"Atherly T, Rossi G, White R, Seo YJ, Wang C, Ackermann M, Breuer M, Allenspach K, Mochel JP, Jergens AE. Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease. PLoS ONE. 2019;14(12):e0226780. https:\/\/doi.org\/10.1371\/journal.pone.0226780.","journal-title":"PLoS ONE"},{"issue":"2","key":"4528_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1939-1676.2009.0447.x","volume":"24","author":"AE Jergens","year":"2010","unstructured":"Jergens AE, Crandell J, Morrison JA, Deitz K, Pressel M, Ackermann M, Suchodolski JS, Steiner JM, Evans R. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial. J Vet Intern Med. 2010;24(2):269\u201377. https:\/\/doi.org\/10.1111\/j.1939-1676.2009.0447.x.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"4528_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jsap.12039","volume":"54","author":"JR Dandrieux","year":"2013","unstructured":"Dandrieux JR, Noble PJ, Halladay LJ, McLean L, German AJ. Canine breed predispositions for marked hypocobalaminaemia or decreased folate concentration assessed by a laboratory survey. J Small Anim Pract. 2013;54(3):143\u20138. https:\/\/doi.org\/10.1111\/jsap.12039.","journal-title":"J Small Anim Pract"},{"issue":"5","key":"4528_CR44","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/jvim.15247","volume":"32","author":"RM Heilmann","year":"2018","unstructured":"Heilmann RM, Steiner JM. Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs. J Vet Intern Med. 2018;32(5):1495\u2013508. https:\/\/doi.org\/10.1111\/jvim.15247.","journal-title":"J Vet Intern Med"},{"key":"4528_CR45","doi-asserted-by":"publisher","unstructured":"Breitr\u00fcck A, Weigel M, Hofrichter J, Sempert K, Kerkhoff C, Mohebali N, Mitzner S, Hain T, Kreikemeyer B. Smectite as a preventive oral treatment to reduce clinical symptoms of DSS induced colitis in balb\/c mice. Int J Mol Sci. 2021;22(16). https:\/\/doi.org\/10.3390\/ijms22168699.","DOI":"10.3390\/ijms22168699"},{"issue":"2","key":"4528_CR46","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10620-014-3360-7","volume":"60","author":"KE Zychowski","year":"2015","unstructured":"Zychowski KE, Elmore SE, Rychlik KA, Ly HJ, Pierezan F, Isaiah A, Suchodolski JS, Hoffmann AR, Romoser AA, Phillips TD. Mitigation of colitis with novasil clay therapy. Dig Dis Sci. 2015;60(2):382\u201392. https:\/\/doi.org\/10.1007\/s10620-014-3360-7.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"4528_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/vco.12631","volume":"19","author":"Q Fournier","year":"2021","unstructured":"Fournier Q, Serra JC, Williams C, Bavcar S. Chemotherapy-induced diarrhoea in dogs and its management with smectite: results of a monocentric open-label randomized clinical trial. Vet Comp Oncol. 2021;19(1):25\u201333. https:\/\/doi.org\/10.1111\/vco.12631.","journal-title":"Vet Comp Oncol"},{"issue":"5","key":"4528_CR48","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1111\/jvim.15571","volume":"33","author":"S Salavati Schmitz","year":"2019","unstructured":"Salavati Schmitz S, Gow A, Bommer N, Morrison L, Mellanby R. Diagnostic features, treatment, and outcome of dogs with inflammatory protein-losing enteropathy. J Vet Intern Med. 2019;33(5):2005\u201313. https:\/\/doi.org\/10.1111\/jvim.15571.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"4528_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jvim.15406","volume":"33","author":"MD Craven","year":"2019","unstructured":"Craven MD, Washabau RJ. Comparative pathophysiology and management of protein-losing enteropathy. J Vet Intern Med. 2019;33(2):383\u2013402. https:\/\/doi.org\/10.1111\/jvim.15406.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"4528_CR50","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1111\/jvim.15752","volume":"34","author":"C Hauck","year":"2020","unstructured":"Hauck C, Schmitz SS, Burgener IA, Wehner A, Neiger R, Kohn B, Rieker T, Reese S, Unterer S. Prevalence and characterization of hypoadrenocorticism in dogs with signs of chronic gastrointestinal disease: a multicenter study. J Vet Intern Med. 2020;34(4):1399\u2013405. https:\/\/doi.org\/10.1111\/jvim.15752.","journal-title":"J Vet Intern Med"},{"key":"4528_CR51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12917-015-0541-3","volume":"11","author":"T Olivry","year":"2015","unstructured":"Olivry T, Mueller RS, Pr\u00e9laud P. Critically appraised topic on adverse food reactions of companion animals (1): duration of elimination diets. BMC Vet Res. 2015;11:225. https:\/\/doi.org\/10.1186\/s12917-015-0541-3.","journal-title":"BMC Vet Res"},{"issue":"3","key":"4528_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/vco.12384","volume":"16","author":"KM Couto","year":"2018","unstructured":"Couto KM, Moore PF, Zwingenberger AL, Willcox JL, Skorupski KA. Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma. Vet Comp Oncol. 2018;16(3):337\u201343. https:\/\/doi.org\/10.1111\/vco.12384.","journal-title":"Vet Comp Oncol"},{"issue":"1","key":"4528_CR53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/vco.12653","volume":"19","author":"H Yamazaki","year":"2021","unstructured":"Yamazaki H, Sasai H, Tanaka M, Tanaka T, Nishida H, Noguchi S, Kuwamura M, Akiyoshi H. Assessment of biomarkers influencing treatment success on small intestinal lymphoma in dogs. Vet Comp Oncol. 2021;19(1):123\u201331. https:\/\/doi.org\/10.1111\/vco.12653.","journal-title":"Vet Comp Oncol"},{"issue":"3","key":"4528_CR54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0300985818813090","volume":"56","author":"KA Allenspach","year":"2019","unstructured":"Allenspach KA, Mochel JP, Du Y, Priestnall SL, Moore F, Slayter M, Rodrigues A, Ackermann M, Krockenberger M, Mansell J, Luckschander N, Wang C, Suchodolski J, Berghoff N, Jergens AE. Correlating gastrointestinal histopathologic changes to clinical disease activity in dogs with idiopathic inflammatory bowel disease. Vet Pathol. 2019;56(3):435\u201343. https:\/\/doi.org\/10.1177\/0300985818813090.","journal-title":"Vet Pathol"},{"key":"4528_CR55","first-page":"10","volume":"22","author":"D Laflamme","year":"1997","unstructured":"Laflamme D. Development and validation of a body condition score system for dogs. Canine Pract. 1997;22:10\u20135.","journal-title":"Canine Pract"},{"key":"4528_CR56","volume-title":"Nutrient requirements of dogs and cats","author":"National Research Council","year":"2006","unstructured":"National Research Council. Nutrient requirements of dogs and cats. Washington, DC: National Academies; 2006."},{"issue":"5","key":"4528_CR57","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2460\/ajvr.2002.63.677","volume":"63","author":"MP Weber","year":"2002","unstructured":"Weber MP, Stambouli F, Martin LJ, Dumon HJ, Biourge VC, Nguyen PG. Influence of age and body size on gastrointestinal transit time of radiopaque markers in healthy dogs. Am J Vet Res. 2002;63(5):677\u201382. https:\/\/doi.org\/10.2460\/ajvr.2002.63.677.","journal-title":"Am J Vet Res"},{"issue":"3","key":"4528_CR58","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1939-1676.2003.tb02450.x","volume":"17","author":"AE Jergens","year":"2003","unstructured":"Jergens AE, Schreiner CA, Frank DE, Niyo Y, Ahrens FE, Eckersall PD, Benson TJ, Evans R. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med. 2003;17(3):291\u20137. https:\/\/doi.org\/10.1111\/j.1939-1676.2003.tb02450.x.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"4528_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1939-1676.2009.0443.x","volume":"24","author":"RJ Washabau","year":"2010","unstructured":"Washabau RJ, Day MJ, Willard MD, Hall EJ, Jergens AE, Mansell J, Minami T, Bilzer TW, Group WIGS. Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. J Vet Intern Med. 2010;24(1):10\u201326. https:\/\/doi.org\/10.1111\/j.1939-1676.2009.0443.x.","journal-title":"J Vet Intern Med"},{"issue":"Suppl 1","key":"4528_CR60","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jcpa.2008.01.001","volume":"138","author":"MJ Day","year":"2008","unstructured":"Day MJ, Bilzer T, Mansell J, Wilcock B, Hall EJ, Jergens A, Minami T, Willard M, Washabau R. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the world small animal veterinary association gastrointestinal standardization group. J Comp Pathol. 2008;138(Suppl 1):S1\u201343. https:\/\/doi.org\/10.1016\/j.jcpa.2008.01.001.","journal-title":"J Comp Pathol"},{"key":"4528_CR61","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing."},{"issue":"43","key":"4528_CR62","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan LDA, Fran\u00e7ois R, Grolemund G, Hayes A, Henry L, Hester J. Welcome to the tidyverse. J Open Source Softw. 2019;4(43):1686.","journal-title":"J Open Source Softw"},{"issue":"1","key":"4528_CR63","first-page":"1","volume":"67","author":"M Douglas Bates","year":"2015","unstructured":"Douglas Bates M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1\u201348.","journal-title":"J Stat Softw"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-025-04528-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-04528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:01:54Z","timestamp":1751864514000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-025-04528-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4528"],"URL":"https:\/\/doi.org\/10.1186\/s12917-025-04528-y","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Review Committee of Royal Canin SAS (protocol code RCIBD-2012, Nov 5, 2012). All dogs had active disease and the clinical procedures used were required for the management of their case. All procedures were conducted in accordance with relevant guidelines (e.g., standard operating procedures) and regulations. The food used in the study was a commercially-available therapeutic diet that was already commonly used by veterinarians for CE, and was fed for the clinical benefit of the study dogs. In the ethical approval granted (protocol code RCIBD-2012), neither the clinical procedures used nor the clinical use of the therapeutic diets were deemed to involve animal experimentation and, therefore, fell outside the remit of national legislation. The owners of all participating dogs gave their informed consent in writing, for clinical management of their CE, for the use of anonymised data and surplus clinical samples for research purposes, and for use of data for publication. All procedures performed were clinical in nature and undertaken for the benefit of the animal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"VB and JL are current employees of Royal Canin SAS, whilst IM was also an employee at the time of the research. Although AJG is an employee of the University of Liverpool, his post is financially supported by Royal Canin. AJG has also received financial remuneration for providing educational material, speaking at conferences, and consultancy work from this company; all such remuneration has been for projects unrelated to the work reported in this manuscript. Royal Canin collaborated on the design of the study, supplied the test diet, performed some of the statistical analyses, participated in the decision to publish the results, funded editorial support and reviewed the manuscript for quality purposes prior to submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}